Read the latest news about the use of biomarkers in research on Alzheimer's prevention.
The data have been compared with Alzheimer's biomarkers of 2,300 people from four cohorts, including participants without cognitive alterations from the ALFA Study, promoted by the ”la Caixa” Foundation.
More than 80 researchers have attended the Biomarkers Workshop, a scientific event with great international impact, organised by the Barcelonaβeta Brain Research Center.
The event, organized together with University College London and the University of Gothenburg, is aimed at PhD students and will take place between the 15th and the 19th of May.
A study led by the Hospital del Mar Medical Research Institute, the Barcelonaβeta Brain Research Centre and the University of Gothenburg has compared the validity of nine biomarkers for the day-to-day diagnosis of Alzheimer's disease in hospital centres.
The study, which used data from almost 400 participants of the ALFA+ Study, determines that the biomarkers p-tau231 and p-tau217 measured in the blood are suitable for indicating brain changes related to the amyloid protein in people without cognitive symptoms.
The organization under the European Commission will finance part of the project
The research, endowed with nearly 1.5 milion euros, will provide a new therapeutic target for Alzheimer's disease, in which age is the most important risk factor
The most prominent congress dedicated to Alzheimer's research has been held completely virtual
The study also points out that, with age, people who have experienced episodes of anxiety or depression in the past have increased hippocampal atrophy